Immunologic features of genitourinary cancer.
D000230:Adenocarcinoma / Q000276:immunology; D000510:Alpha-Globulins; D000818:Animals; D000917:Antibody Formation; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002272:Carcinoembryonic Antigen / Q000302:isolation & purification; D002295:Carcinoma, Transitional Cell / Q000276:immunology; D002822:Choriocarcinoma / Q000276:immunology; D003110:Colonic Neoplasms / Q000276:immunology; D006224:Cricetinae; D004407:Dysgerminoma / Q000276:immunology; D005326:Fetal Proteins; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000276:immunology; D008297:Male; D051379:Mice; D009447:Neuroblastoma / Q000276:immunology; D011471:Prostatic Neoplasms / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D013736:Testicular Neoplasms / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000276:immunology; D014565:Urogenital Neoplasms / Q000276:immunology*
D000510:Alpha-Globulins; D000951:Antigens, Neoplasm; D001500:BCG Vaccine; D002272:Carcinoembryonic Antigen; D005326:Fetal Proteins